PMD Device Solutions Beheer
Beheer criteriumcontroles 0/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Myles Murray
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 13.8yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | less than a year |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -SEK 44m |
| Mar 31 2024 | n/a | n/a | -SEK 39m |
| Dec 31 2023 | n/a | n/a | -SEK 39m |
| Mar 31 2023 | SEK 4m | SEK 2m | -SEK 36m |
Compensatie versus markt: Insufficient data to establish whether Myles's total compensation is reasonable compared to companies of similar size in the Swedish market.
Compensatie versus inkomsten: Insufficient data to compare Myles's compensation with company performance.
CEO
Myles Murray (38 yo)
13.8yrs
Tenure
SEK 4,395,000
Compensatie
Mr. Myles Murray is Founder, CEO and Director of PMD Device Solutions Limited. He serves as Director at Promore Pharma AB (publ) since December 29, 2023. He serves as CEO since 2011 and Director at PMD Dev...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Director | 3.8yrs | SEK 4.40m | geen gegevens | |
| Chairman Of The Board | less than a year | geen gegevens | geen gegevens | |
| Director | less than a year | geen gegevens | geen gegevens |
0.08yrs
Gemiddelde duur
49yo
Gemiddelde leeftijd
Ervaren bestuur: PMDS's board of directors are not considered experienced ( 0.1 years average tenure), which suggests a new board.